
Foley & Lardner LLP will be attending the Infocast CCS/ Decarbonization Project Development, Finance & Investment Summit at the Hilton Houston Post Oak. Sarah Slack and Peter Tomasi, Foley partners, will moderate panel discussions on the first two days of the Main Summit, followed by the Executive Briefing. Sarah will cover “Permitting and its Impact on Project Investment, Financing, and Costs,” while Peter will explore “Pipeline Owner/Operators Perspectives: Infrastructure Build-out and its Influence on Project Valuation and Bankability.” We are a proud sponsor of the event and look forward to seeing you there.
For more information and the full agenda, click here.
People
Related Insights
21 April 2025
Health Care Law Today
Prescription Drugs: Executive Order Aims to Lower Prices
On April 15, 2025, President Trump signed an executive order (EO) with the aim of reducing the cost of prescription drugs.
21 April 2025
Health Care Law Today
MedTech Round Table: What the Trump Administration Means for Companies and Investors
Foley & Lardner LLP hosted and participated in a MedTech round table of investors and business leaders, including chief executive officers, partners, directors, innovation leads, investment funds managers and partners, and general counsels. There was collective interest in understanding how these MedTech leaders are adjusting to the changing business and regulatory environment under the second Trump administration.
21 April 2025
Labor & Employment Law Perspectives
Supreme Court’s E.M.D. Sales v. Carrera Decision: A Victory for Employers Navigating FLSA Exemptions
In the case at issue, E.M.D. Sales, Inc. v. Carrera, the court clarified the applicable standard of proof, ruling that employers need only demonstrate by a "preponderance of the evidence," the standard used in most civil cases, that an employee qualifies for an FLSA exemption, rather than the higher more stringent "clear and convincing evidence" standard previously applied by the Fourth Circuit Court of Appeals.